Thanks for sharing, it is nice to see Redleaf covering. I think FND is well below where it should be but have several issues with Refleaf valuation:
1) It seems like they are valuing TSI, not FND's share in TSI (a tad over 80%)
2) Share count will rise with option exercise. If price goes below exercise price and options become worthless you would think many players would have interest in getting 10% stake to block a takeover/under (e.g. competitors for takeover/big investors for under), so think SOI should be above 50 mil and assume full dilution.
3) Risk weighting is excessive Parimal just gave a valuation and are invested on basis of IPO. Maybe this is explained in the report but it's a valuation technique I've not seen.
4) I know Parimal used EV/EBITDA but don't understand why this is applied. TSI is an ATM business and machines depreciate. EV/EBITDA is great for mines, but not for FND/TSI that is more like a REIT. I know it is what FND use in presos and Parimal used for valuation, but the logic isn't really clear.
I recognise some of this feedback is a bit harsh, but I strongly think this sort of valuation is unnecessary. Based on the Parimal transaction, they have valued FND’s stake of the TSI business at $183 million or roughly $3.12 per share, and put $37.6 million at risk based on this valuation which you would think as a minimum given they would expect to be coming out ahead at IPO (max 3 years from now). As a small ASX investor, this seems like a no brainer to me given what Parimal paid.
HY results due soon and hopefully WL ann before XMAS should give SP a boost.
- Forums
- ASX - By Stock
- Ann: Trading Halt
FND
findi limited
Add to My Watchlist
0.24%
!
$4.17

Thanks for sharing, it is nice to see Redleaf covering. I think...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.17 |
Change
0.010(0.24%) |
Mkt cap ! $257.7M |
Open | High | Low | Value | Volume |
$4.20 | $4.29 | $4.12 | $370.0K | 88.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5122 | $4.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.40 | 11620 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1210 | 4.120 |
1 | 1898 | 4.110 |
2 | 10000 | 4.100 |
1 | 4000 | 4.050 |
4 | 7496 | 4.000 |
Price($) | Vol. | No. |
---|---|---|
4.400 | 11620 | 1 |
4.440 | 5000 | 1 |
4.570 | 1666 | 1 |
4.580 | 622 | 1 |
4.590 | 800 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
FND (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online